tradingkey.logo
tradingkey.logo
Search

Bicycle Therapeutics PLC

BCYC
Add to Watchlist
3.875USD
-0.285-6.85%
Close 07-23 16:00ETQuotes delayed by 15 min
194.79MMarket Cap
LossP/E TTM

BCYC Financials

See Bicycle Therapeutics PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Bicycle Therapeutics PLC Earnings Date

Latest Release
Apr 30, 2026
EPS / Forecast
-0.87/-0.62
Revenue / Forecast
887.00K/7.27M
Period
FY2025 Earnings
Revenue(YoY)
72.59M
105.77%
EPS(YoY)
-3.16
-8.84%
Analyst Rating
BUY
2026/07/24
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
0.58%-0.87
61.26%-0.29
-15.81%-0.85
-48.89%-1.14
-40.67%-0.88
35.08%-0.75
41.59%-0.74
45.73%-0.77
52.07%-0.62
-14.52%-1.16
---1.26
---1.41
---1.30
---1.01
---2.79
----
----
----
----
----
Revenue
-91.11%887.00K
1193.28%47.95M
338.49%11.73M
-68.81%2.92M
-48.91%9.98M
-30.44%3.71M
-50.00%2.68M
-17.86%9.36M
298.90%19.53M
67.38%5.33M
76.05%5.35M
160.32%11.40M
26.84%4.90M
-15.54%3.19M
-29.84%3.04M
145.27%4.38M
113.50%3.86M
-2.00%3.77M
12.78%4.33M
13.62%1.79M
Net Profit
-0.12%-60.83M
61.13%-20.15M
-16.33%-59.10M
-98.31%-78.95M
-128.72%-60.75M
-5.61%-51.85M
-1.81%-50.80M
6.55%-39.81M
32.00%-26.56M
-63.78%-49.10M
-76.03%-49.90M
-58.80%-42.60M
-41.72%-39.06M
-66.20%-29.98M
-93.13%-28.35M
-49.77%-26.83M
-70.24%-27.56M
-3.46%-18.04M
-44.78%-14.68M
-47.86%-17.91M
Net Margin
-1026.12%-6857.38%
96.99%-42.03%
73.47%-503.66%
-535.75%-2703.84%
-347.71%-608.94%
-51.84%-1398.44%
-103.62%-1898.43%
-13.77%-425.30%
82.95%-136.01%
2.15%-921.01%
---932.32%
---373.81%
---797.88%
---941.22%
---733.63%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
12.47%0.12%
17.49%0.12%
573.11%0.12%
-95.94%0.12%
-98.04%0.11%
-97.99%0.10%
-99.62%0.02%
-56.49%2.92%
-20.64%5.63%
-30.16%5.16%
--4.79%
--6.72%
--7.09%
--7.38%
--7.25%
----
----
----
----
----
Revenue
-91.11%887.00K
1193.28%47.95M
338.49%11.73M
-68.81%2.92M
-48.91%9.98M
-30.44%3.71M
-50.00%2.68M
-17.86%9.36M
298.90%19.53M
67.38%5.33M
76.05%5.35M
160.32%11.40M
26.84%4.90M
-15.54%3.19M
-29.84%3.04M
145.27%4.38M
113.50%3.86M
-2.00%3.77M
12.78%4.33M
13.62%1.79M
Operating profit
6.31%-65.59M
63.25%-24.66M
-3.43%-65.71M
-86.85%-87.35M
-120.23%-70.00M
-23.29%-67.09M
-26.84%-63.53M
-7.46%-46.75M
23.13%-31.79M
-68.74%-54.42M
-67.17%-50.08M
-63.41%-43.50M
-51.63%-41.35M
-76.56%-32.25M
-107.36%-29.96M
-54.02%-26.62M
-70.64%-27.27M
-7.06%-18.27M
-35.34%-14.45M
-37.35%-17.28M
Net Profit
-0.12%-60.83M
61.13%-20.15M
-16.33%-59.10M
-98.31%-78.95M
-128.72%-60.75M
-5.61%-51.85M
-1.81%-50.80M
6.55%-39.81M
32.00%-26.56M
-63.78%-49.10M
-76.03%-49.90M
-58.80%-42.60M
-41.72%-39.06M
-66.20%-29.98M
-93.13%-28.35M
-49.77%-26.83M
-70.24%-27.56M
-3.46%-18.04M
-44.78%-14.68M
-47.86%-17.91M
Current assets
-27.68%619.13M
-26.46%682.88M
-23.53%738.82M
-21.78%804.26M
65.92%856.09M
65.27%928.61M
60.22%966.19M
151.76%1.03B
35.33%515.96M
52.11%561.87M
58.16%603.04M
-0.02%408.43M
-11.29%381.25M
-19.45%369.38M
39.73%381.29M
87.56%408.49M
99.53%429.77M
194.47%458.56M
66.23%272.87M
93.54%217.79M
Total current liabilities
-15.16%48.89M
-15.24%56.98M
22.83%69.28M
11.22%77.42M
16.39%57.62M
-3.32%67.23M
-19.12%56.41M
-3.67%69.61M
-6.58%49.51M
30.36%69.54M
67.83%69.74M
74.80%72.27M
49.64%52.99M
47.20%53.34M
37.69%41.55M
77.64%41.34M
70.21%35.41M
56.68%36.24M
77.02%30.18M
37.08%23.27M
Total assets
-26.19%652.40M
-25.01%717.60M
-23.36%763.95M
-21.30%832.18M
61.55%883.89M
60.73%956.87M
56.06%996.75M
132.81%1.06B
27.60%547.14M
44.99%595.34M
53.11%638.68M
1.95%454.17M
-6.69%428.80M
-14.42%410.61M
48.28%417.15M
97.07%445.48M
105.31%459.56M
197.73%479.79M
65.43%281.33M
90.59%226.05M
Total liabilities
-31.68%98.08M
-34.30%107.62M
-12.21%145.47M
-11.05%163.27M
-24.87%143.56M
-27.01%163.81M
-25.58%165.71M
-21.59%183.54M
2.94%191.09M
60.49%224.41M
74.40%222.66M
74.56%234.07M
43.57%185.64M
4.71%139.83M
15.53%127.67M
59.63%134.09M
58.17%129.31M
103.28%133.54M
82.64%110.51M
76.56%84.00M
Total equity
-25.13%554.32M
-23.09%609.98M
-25.58%618.48M
-23.45%668.91M
107.93%740.33M
113.80%793.06M
99.76%831.03M
297.01%873.81M
46.42%356.05M
36.98%370.93M
43.72%416.02M
-29.32%220.10M
-26.37%243.16M
-21.80%270.78M
69.46%289.47M
119.21%311.39M
132.43%330.26M
262.72%346.25M
55.93%170.82M
100.00%142.05M
Net operating income
23.67%-65.92M
-105.90%-19.35M
-78.68%-71.17M
-63.10%-72.79M
-21.87%-86.37M
80.13%-9.40M
-3786.05%-39.83M
-230.89%-44.63M
-52.70%-70.87M
-56.02%-47.29M
82.54%-1.02M
244.90%34.10M
-75.80%-46.41M
-190.46%-30.31M
-127.03%-5.87M
-90.23%-23.53M
-92.60%-26.40M
37.20%-10.44M
317.51%21.72M
-0.17%-12.37M
Net investment
-18.05%-713.00K
-55.98%-574.00K
-54.94%-674.00K
-18.57%-498.00K
-4933.33%-604.00K
-621.57%-368.00K
13.35%-435.00K
-51.62%-420.00K
99.43%-12.00K
96.48%-51.00K
83.18%-502.00K
97.17%-277.00K
55.87%-2.10M
-35.71%-1.45M
-1665.68%-2.98M
-5630.41%-9.80M
-663.40%-4.76M
-120.45%-1.07M
-77.89%-169.00K
43.19%-171.00K
Net financing
-31.71%-54.00K
-107.39%-15.00K
99.91%-30.00K
-100.01%-45.00K
-102.19%-41.00K
-47.41%203.00K
-113.61%-31.93M
4371.25%549.61M
-31.16%1.87M
-93.44%386.00K
147466.67%234.63M
6203.59%12.29M
504.00%2.72M
-96.91%5.89M
-99.61%159.00K
-98.75%195.00K
-99.39%450.00K
10832.57%190.66M
-33.78%40.45M
155420.00%15.55M

FAQs

What is the total revenue of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its total revenue reached 72.59M, with a year-on-year change of 35.27M.

What are the current assets of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its current assets were 682.88M, with a year-on-year change of -26.46.

What are the total assets of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its total assets of Bicycle Therapeutics PLC were 717.60M, with a year-on-year change of -25.01.

What are the total liabilities of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its total liabilities of Bicycle Therapeutics PLC were 107.62M, with a year-on-year change of -34.30.

What is the total equity of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its total equity of Bicycle Therapeutics PLC was 609.98M, with a year-on-year change of -23.09.

What is the net operating income of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its net operating income of Bicycle Therapeutics PLC was -247.72M, with a year-on-year change of -18.44.

What is the net investment of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its net investment of Bicycle Therapeutics PLC was -2.35M, with a year-on-year change of -90.28.

What is the net financing of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its net financing of Bicycle Therapeutics PLC was -131.00K, with a year-on-year change of -100.03.

What is the Earnings Per Share (EPS) of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -3.16, with a year-on-year change of -8.84.

What is the net income of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its net income was -218.96M, with a year-on-year change of -29.54.

What is the net margin of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its net profit margin was -301.66, with a year-on-year change of 37.05.

What is the debt-to-asset ratio of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its debt-to-asset ratio was 0.12, with a year-on-year change of 17.49.

What is the Return on Equity (ROE) of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its Return on Equity (ROE) was -31.21, with a year-on-year change of -7.47.

What is the Return on Assets (ROA) of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its Return on Assets (ROA) was -26.15, with a year-on-year change of -20.08.

What is the operating profit of Bicycle Therapeutics PLC?

According to Bicycle Therapeutics PLC's FY2025 earnings report, its operating profit was -247.72M, with a year-on-year change of -18.44.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.